Please Wait
Applying Filters...
Menu
Xls

Digital Content read-more

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.onclive.com/view/lirafugratinib-elicits-durable-responses-across-several-fgfr2-solid-tumors

ONCLIVE
13 Oct 2023

https://www.globenewswire.com//news-release/2023/10/12/2759649/0/en/Relay-Therapeutics-Announces-Initial-RLY-4008-lirafugratinib-Data-Demonstrating-Durable-Responses-Across-Multiple-FGFR2-Altered-Solid-Tumors.html

GLOBENEWSWIRE
12 Oct 2023